Local Therapy in Advanced Cholangiocarcinoma: A Review of Current Endoscopic, Medical, and Oncologic Treatment Options-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Local Therapy in Advanced Cholangiocarcinoma: A Review of Current Endoscopic, Medical, and Oncologic Treatment Options

Published:2019 Issue:4 Volume:97 Page:191-201
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Jung Carlo Felix Maria,Lavole Julie,Barret Maximilien,Abou Ali Einas,Palmieri Lola-Jade,Dermine Solene,Barré Amélie,Chaussade Stanislas,Coriat Romain

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference74 articles.

1. Valle JW, Borbath I, Khan SA, Huguet F, Gruenberger T, Arnold D; ESMO Guidelines Committee. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016 Sep;27 suppl 5:v28–37.

2. Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014 Jun;383(9935):2168–79.

3. Abou-Alfa GK, Andersen JB, Chapman W, Choti M, Forbes SJ, Gores GJ, et al. Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference. J Gastrointest Oncol. 2016 Dec;7(6):819–27.

4. Bergquist A, von Seth E. Epidemiology of cholangiocarcinoma. Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):221–32.

5. Schulick RD. Criteria of unresectability and the decision-making process. HPB (Oxford). 2008;10(2):122–5.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in research and application of photodynamic therapy in cholangiocarcinoma (Review);Oncology Reports;2024-02-02

2. Current Status and Progress in the Treatment of Hilar Cholangiocarcinoma;Advances in Clinical Medicine;2024

3. Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial;Journal of Cancer Research and Clinical Oncology;2023-05-11

4. The reality of cholangiocarcinoma in India– real world data from a tertiary referral centre;HPB;2022-09

5. Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma;Expert Opinion on Investigational Drugs;2021-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3